Products | GSK US
GSK US offers a wide range of products, including vaccines for infectious diseases, specialty medicines for HIV, respiratory, immunology and oncology, and general medicines for asthma, COPD, skin and more. Find the full list of products available in the US and access more information on GSKPro website.
Home | GSK US
GSK is a global biopharmaceutical company that develops and manufactures vaccines, medicines and consumer health products. Learn about its latest news, innovations, careers and social responsibility initiatives.
Oncology | GSK US
GSK Oncology is a purpose-built organization that develops and delivers medicines for people with rare and gynecologic cancers. Learn about their programs, products, and commitment to health equity and innovation.
Vaccines | GSK US
GSK US develops and delivers vaccines to protect people from serious diseases, such as flu, meningitis, RSV, shingles and more. Learn about the history, impact and innovation of GSK's vaccines portfolio and pipeline.
Respiratory - GSK US
GSK is a leader in respiratory care, with over 50 years of research and development for asthma treatments. Learn about the different types of asthma, the role of eosinophils, and how to manage symptoms and live well with asthma.
Specialty | GSK US
GSK US Specialty Health focuses on research and development of innovative treatments for lupus, lupus nephritis, and eosinophil-driven diseases. Learn about the science, partnerships, and commitments of GSK US in this field.
Company | GSK US
GSK is a global healthcare company with a significant presence in the US. It focuses on oncology, respiratory, specialty, vaccines and HIV, and has policies on various issues.
Press releases | GSK US
Find the latest news and announcements from GSK US, a global healthcare company. Learn about its products, research, awards, partnerships and social impact in various categories and dates.
GSK announces cap of $35 per month on U.S. patient out-of …
GSK announced it will limit out-of-pocket costs for eligible patients to $35 per month for its entire portfolio of asthma and COPD medicines, effective from January 2025. This is part of GSK's commitment to making respiratory products accessible and affordable in the U.S.
At a glance | GSK US
GSK US is a global healthcare company that develops and sells vaccines, medicines and treatments for various diseases. Learn about its portfolio, culture, contributions to public health challenges such as COVID, AMR, pricing, patient assistance programs and more.